Introduction
Following the patent expiries of angiotensin-II receptor blockers Datamonitor expects antihypertensives sales in the seven major markets to record sales of $29.5 billion in 2018, a drop of over $6 billion compared to 2008.
Reasons to Purchase
*Quantify the future size of the antihypertensives market and identify opportunities for new products.
*Learn how recent changes related to product expiries will shape the antihypertensives market.
*Understand the barriers to uptake for novel antihypertensive agents, and the need for paradigm shift in clinical trial design.
Other selected research from the 'Markets' category:
Indian Biofuel Industry
This report provides research and objective analysis of Biofuels industry in India. This report helps clients to evaluate the current status and opportunities in the Indian Biofuels market. Learn More
Attention-Deficit Hyperactivity Disorder Market Forecast
Driven primarily by continued uptake of Shire’s market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408) of 13.5% to reach almost $4.4 billion in 2008. Learn More